Additional data released in the American Society of Anesthesiologist's survey of more than 3,000 anesthesiologists reveals that more than two thirds of respondents are currently experiencing a shortage of fentanyl.
The full survey, released Tuesday, shows that 66 percent of anesthesiologists are seeing a shortage in fentanyl, followed by thiopental (40 percent), succinylcholine (20 percent), propofol (19 percent) and pancuronium (15 percent). Anesthesiologists also noted that as a result of these shortages, patients experienced post-operative nausea and vomiting (66 percent) and longer OR and recovery times (52 percent).
Initial survey data indicated that at least seven patient deaths had occurred as a result of the nationwide anesthesia drug shortage.
Florida Gulf-to-Bay Anesthesiology Associates Partners With Private Equity Firm
Medicare ACOs Are Blooming (With or Without Anesthesiologists)
The full survey, released Tuesday, shows that 66 percent of anesthesiologists are seeing a shortage in fentanyl, followed by thiopental (40 percent), succinylcholine (20 percent), propofol (19 percent) and pancuronium (15 percent). Anesthesiologists also noted that as a result of these shortages, patients experienced post-operative nausea and vomiting (66 percent) and longer OR and recovery times (52 percent).
Initial survey data indicated that at least seven patient deaths had occurred as a result of the nationwide anesthesia drug shortage.
Related Articles on Anesthesia:
Anesthesiologist Studies Survival Rate of Helicopter Transport PatientsFlorida Gulf-to-Bay Anesthesiology Associates Partners With Private Equity Firm
Medicare ACOs Are Blooming (With or Without Anesthesiologists)